Earli
Evan Bishop has worked in the scientific field since 2012. Evan began their career at Stemcentrx, Inc., where they served as an Oncology Discovery Research Associate II, Oncology Discovery Research Associate I, and In Vivo Research Associate I from 2012 to 2016. Evan then moved to AbbVie, where they were an Oncology Discovery Scientist I from 2016 to 2017. In 2017, they joined Kenjockety Biotechnology LLC as a Scientist. Since 2018, Evan has been an Associate Principal Scientist, Senior Scientist, and Scientist at Earli Inc.
Evan Bishop attended the University of California, Los Angeles from 2007 to 2011, where they earned a Bachelor's degree in Biology.
This person is not in any offices
Earli
1 followers
Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.